Non-viral gene therapy vectors are particularly attractive for research and pharmaceutical development. The ideal vector would be of small size, be non-aggregating, targetable to specific cell types, highly efficient, and simple to formulate. The authors propose a novel approach in which DNA is condensed into small particles using a template polymerization approach. This approach allows flexibility in using both cationic and non-cationic compounds for condensation, and opens the possibility of incorporating targeting ligands during polymerization.
The specific aims of the proposal include: 1) Characterization of novel polymerization processes for reproducible preparation of small DNA-containing particles; 2) Physico-chemical characterization to determine which types of cationic compounds are optimal for production of stable, non-aggregating particles; and 3) Incorporation of specific ligands and endosome disrupting moieties in the particle formation process.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43GM057753-01
Application #
2649450
Study Section
Special Emphasis Panel (ZRG2-SSS-Y (02))
Program Officer
Beisler, John A
Project Start
1998-08-01
Project End
1999-01-31
Budget Start
1998-08-01
Budget End
1999-01-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Mirus Bio Corporation
Department
Type
DUNS #
937904944
City
Madison
State
WI
Country
United States
Zip Code
53711